FOXH1 Gene Congenital Heart Disease and Transposition of the Great Arteries Genetic Test sale cost 4400 AED
SNAP29 Gene Cerebral Dysgenesis Neuropathy Ichthyosis Palmoplantar Keratoderma Syndrome Genetic Test sale cost 4400 AED SNAP29 Gene Cerebral Dysgenesis Neuropathy Ichthyosis Palmoplantar Keratoderma Syndrome Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
TCF12 Gene Craniosynostosis Type 3 Genetic Test sale cost 4400 AED TCF12 Gene Craniosynostosis Type 3 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

FOXH1 Gene Congenital Heart Disease and Transposition of the Great Arteries Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “FOXH1 Gene Congenital Heart Disease and Transposition of the Great Arteries Genetic Test” is a specialized diagnostic examination conducted to identify mutations in the FOXH1 gene that are associated with congenital heart diseases, particularly Transposition of the Great Arteries (TGA). This condition is a serious congenital heart defect where the two main arteries leaving the heart are reversed, leading to significant complications in blood circulation. The test aims to provide crucial genetic information that can aid in the early diagnosis, management, and treatment planning for affected individuals.

Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test utilizes advanced genomic technologies to accurately detect any genetic abnormalities linked to these heart conditions. By analyzing a small sample of the patient’s DNA, the test can identify specific mutations in the FOXH1 gene that are known to contribute to the development of congenital heart diseases.

The cost of the FOXH1 Gene Congenital Heart Disease and Transposition of the Great Arteries Genetic Test is set at 4400 AED. This price reflects the comprehensive nature of the test, covering the expenses associated with the sophisticated genetic analysis and the expertise required to interpret the results accurately.

For families with a history of congenital heart disease or individuals showing symptoms related to TGA, this test provides an invaluable tool for early detection and intervention, potentially improving the outcomes and quality of life for those affected.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

FOXH1 Gene Congenital Heart Disease and Transposition of the Great Arteries Genetic Test

Cost: AED 4400.0

Test Components:

  • Price: AED 4400.0
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Dysmorphology
  • Doctor: Pediatrics
  • Test Department: Genetics

Pre Test Information:

Clinical History of Patient who is going for FOXH1 Gene Congenital heart disease and transposition of the great arteries NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FOXH1 Gene Congenital heart disease and transposition of the great arteries NGS Genetic DNA Test gene FOXH1.

Test Details:

The FOXH1 gene is a transcription factor that plays a crucial role in the development of various organs, including the heart. Mutations in the FOXH1 gene have been associated with congenital heart disease, including transposition of the great arteries (TGA). Congenital heart disease refers to structural abnormalities in the heart that are present at birth. TGA is a specific type of congenital heart defect where the two main arteries leaving the heart, the pulmonary artery and the aorta, are switched in position. This results in oxygen-poor blood being circulated to the body instead of being pumped to the lungs for oxygenation.

Next-generation sequencing (NGS) genetic testing is a powerful tool used to identify genetic variations and mutations associated with various diseases, including congenital heart disease. It allows for the simultaneous analysis of multiple genes, providing a comprehensive view of the genetic factors contributing to the disease. NGS genetic testing can help identify specific mutations in the FOXH1 gene that may be causing congenital heart disease, including TGA. This information can be used for accurate diagnosis, prognosis, and potentially for personalized treatment approaches.

It is important to note that genetic testing should be performed by a qualified healthcare professional who specializes in genetics. They will be able to interpret the results and provide appropriate counseling and guidance based on the individual’s specific genetic profile and medical history.

Test Name FOXH1 Gene Congenital heart disease and transposition of the great arteries Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for FOXH1 Gene Congenital heart disease and transposition of the great arteries NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FOXH1 Gene Congenital heart disease and transposition of the great arteries NGS Genetic DNA Test gene FOXH1
Test Details

The FOXH1 gene is a transcription factor that plays a crucial role in the development of various organs, including the heart. Mutations in the FOXH1 gene have been associated with congenital heart disease, including transposition of the great arteries (TGA).

Congenital heart disease refers to structural abnormalities in the heart that are present at birth. TGA is a specific type of congenital heart defect where the two main arteries leaving the heart, the pulmonary artery and the aorta, are switched in position. This results in oxygen-poor blood being circulated to the body instead of being pumped to the lungs for oxygenation.

Next-generation sequencing (NGS) genetic testing is a powerful tool used to identify genetic variations and mutations associated with various diseases, including congenital heart disease. It allows for the simultaneous analysis of multiple genes, providing a comprehensive view of the genetic factors contributing to the disease.

NGS genetic testing can help identify specific mutations in the FOXH1 gene that may be causing congenital heart disease, including TGA. This information can be used for accurate diagnosis, prognosis, and potentially for personalized treatment approaches.

It is important to note that genetic testing should be performed by a qualified healthcare professional who specializes in genetics. They will be able to interpret the results and provide appropriate counseling and guidance based on the individual’s specific genetic profile and medical history.

SKU: TEST-4060 Category:

Related products